Iridian Asset Management LLC CT grew its holdings in Herbalife Ltd (NYSE:HLF - Free Report) by 10.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,775,430 shares of the company's stock after purchasing an additional 267,690 shares during the period. Herbalife makes up 7.5% of Iridian Asset Management LLC CT's investment portfolio, making the stock its 2nd largest position. Iridian Asset Management LLC CT owned 2.74% of Herbalife worth $23,952,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Vanguard Group Inc. lifted its stake in Herbalife by 7.5% during the 4th quarter. Vanguard Group Inc. now owns 11,271,417 shares of the company's stock worth $75,406,000 after acquiring an additional 785,574 shares in the last quarter. Renaissance Technologies LLC increased its holdings in Herbalife by 9.9% during the 4th quarter. Renaissance Technologies LLC now owns 7,088,868 shares of the company's stock worth $47,425,000 after purchasing an additional 638,567 shares during the period. Long Focus Capital Management LLC increased its holdings in Herbalife by 27.3% during the 4th quarter. Long Focus Capital Management LLC now owns 4,758,127 shares of the company's stock worth $31,832,000 after purchasing an additional 1,020,127 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in Herbalife by 777.0% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,987,490 shares of the company's stock worth $19,986,000 after purchasing an additional 2,646,848 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Herbalife by 8.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,696,560 shares of the company's stock worth $18,040,000 after purchasing an additional 216,603 shares during the period.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on HLF shares. DA Davidson upgraded Herbalife from a "neutral" rating to a "buy" rating and upped their price target for the stock from $7.50 to $14.00 in a report on Friday, March 21st. Wall Street Zen raised Herbalife from a "hold" rating to a "buy" rating in a research report on Friday, May 30th. Finally, Citigroup cut their target price on Herbalife from $13.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $11.50.
Check Out Our Latest Research Report on Herbalife
Insider Buying and Selling at Herbalife
In other Herbalife news, Director Juan Miguel Mendoza purchased 5,000 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The shares were acquired at an average price of $6.75 per share, for a total transaction of $33,750.00. Following the completion of the purchase, the director owned 166,857 shares in the company, valued at $1,126,284.75. The trade was a 3.09% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders bought a total of 13,143 shares of company stock valued at $90,973 over the last ninety days. 1.73% of the stock is owned by corporate insiders.
Herbalife Stock Performance
HLF stock traded down $0.21 during midday trading on Friday, hitting $10.16. 1,428,059 shares of the stock were exchanged, compared to its average volume of 2,186,271. Herbalife Ltd has a fifty-two week low of $5.04 and a fifty-two week high of $12.79. The stock has a market cap of $1.03 billion, a price-to-earnings ratio of 3.71, a PEG ratio of 0.31 and a beta of 0.89. The stock's 50-day moving average price is $8.00 and its 200-day moving average price is $7.39.
Herbalife (NYSE:HLF - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The company reported $0.59 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.19. The company had revenue of $1.22 billion during the quarter, compared to analysts' expectations of $1.23 billion. Herbalife had a negative return on equity of 23.75% and a net margin of 5.66%. The business's revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.49 earnings per share. Research analysts anticipate that Herbalife Ltd will post 1.57 EPS for the current year.
Herbalife Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Articles

Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.